The Board of Directors at their meeting held today i.e., on July 29, 2019, have approved the un-audited Financial Results along with Limited Review Report of the Statutory Auditors for the quarter ended June 30, 2019 and an Interim Dividend of Rs. 12/- per share on equity shares of Rs. 10/- each. In this regard, please find enclosed herewith the Press Release tilted Strides announces a healthy Q1FY20 performance along with Un-audited Financial Results (Standalone and Consolidated) & Limited Review Report for the quarter ended June 30, 2019. The board meeting commenced at 14:00 hrs and concluded at 15:45 hrs.

Pdf Link: Strides Pharma Science Ltd - Outcome Of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30, 2019

Source : BSE - www.bseindia.com